MedPath

Transcranial Magnetic Treatment (TMS) in Unipolar Depression

Early Phase 1
Completed
Conditions
Unipolar Depression
Registration Number
NCT00186784
Lead Sponsor
St. Joseph's Healthcare Hamilton
Brief Summary

Repetitive Transcranial Magnetic Stimulation (rTMS) can improve mood and decrease sadness in patients with depression.

In this study, the investigators seek to increase their understanding about how rTMS improves depression, and to determine which form of rTMS is most effective for depression, when used in combination with antidepressant medication.

Detailed Description

Patients will be assigned for 4 treatment arms, receiving either left high frequency plus right low frequency, or left high frequency plus right sham, or left sham, plus right low frequency, or left sham plus right sham treatment. All subjects will receive treatments for 10 days and will be followed for another 4 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Major Depression
  • No physical health problems
Exclusion Criteria
  • History of Epilepsy
  • Metal in the head/neck or skull
  • Pacemaker
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Hamilton Depression Rating ScalePre TMS and post TMS
Beck Depression Rating Scalepre TMS and post TMS
Secondary Outcome Measures
NameTimeMethod
Quantitive Electroencephalographic(QEEG)activity and measures of regional cerebral blood flowpre TMS and post TMS as well as post phase II, second set of TMS

Trial Locations

Locations (1)

St.Joseph's Healthcare, rTMS Laboratory, Mood Disorders Program, 100 West Fifth Street

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath